The role of immunosuppressive agents in the management of severe and refractory immune‐related adverse events-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The role of immunosuppressive agents in the management of severe and refractory immune‐related adverse events

Published:2020-03-24 Issue:4 Volume:16 Page:201-210
ISSN:1743-7555
Container-title:Asia-Pacific Journal of Clinical Oncology
language:en
Short-container-title:Asia‐Pac J Clin Oncol

Author:

Wang Anqi¹^ORCID,Xu Yan²,Fei Yunyun¹,Wang Mengzhao²

Affiliation:

1. Department of Rheumatology and ImmunologyPeking Union Medical College HospitalChinese Academy of Medical Sciences and Peking Union Medical College Beijing China

2. Department of Respiratory MedicinePeking Union Medical College HospitalChinese Academy of Medical Sciences and Peking Union Medical College Beijing China

Funder

National Natural Science Foundation of China

Chinese Academy of Meteorological Sciences

Publisher

Wiley

Subject

Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ajco.13332

Reference103 articles.

1. The CD28 ligand B7/BB1 provides costimulatory signal for alloactivation of CD4+ T cells.

2. CD28 delivers a costimulatory signal involved in antigen specific IL‐2 production by human T cells;Jenkins MK;J Immunol,1991

3. The B7–CD28 superfamily

4. CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation.

5. CTLA-4-Mediated Inhibition in Regulation of T Cell Responses: Mechanisms and Manipulation in Tumor Immunotherapy

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardiotoxicity of checkpoint inhibitors: focus on immune side effects;Medical alphabet;2024-05-09

2. Second-line therapies for steroid-refractory immune-related adverse events in patients treated with immune checkpoint inhibitors;European Journal of Cancer;2024-05

3. Cardiotoxicity of checkpoint inhibitors: focus on immune side effects;Heart, Vessels and Transplantation;2024-04-21

4. The role of microbiomes in gastrointestinal cancers: new insights;Frontiers in Oncology;2024-02-01

5. Rituximab in Pemphigus Vulgaris: A Review of Monoclonal Antibody Therapy in Dermatology;Cureus;2023-06-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3